• You are here: Home
  • Secukinumab Monoclonal Antibody Drug. Targets Interleukin-17A (IL-17A) And Is Used In Treatment Of Psoriasis. Generic Name And
Secukinumab monoclonal antibody drug. Targets interleukin-17A (IL-17A) and is used in treatment of psoriasis. Generic name and

  • Preview image in your
    Facebook Timeline Account

  • Preview

  • Price: 1$
  • Size Facebook: 1702 x 630 px
  • Size Twitter: 1500 x 500 px
  • Size LinkedIn: 1128 x 191 px

More Facebook, Twitter and LinkedIn Cover Photos

More

Cover photo info

  • Photo title: Secukinumab monoclonal antibody drug. Targets interleukin-17A (IL-17A) and is used in treatment of psoriasis. Generic name and
  • Author: Molekuul
  • Cover photo description:
  • Secukinumab monoclonal antibody drug. Targets interleukin-17A (IL-17A) and is used in treatment of psoriasis. Generic name and stylized antibody representation
  • Image ID:186810441
  • Views:0
  • Downloads:2

Keywords for Facebook, Twitter and LinkedIn timeline photos

ankylosing antibody biological biosimilar biotech biotechnology cytokine dermatologic dermatology disease drug il17a immunoglobulin immunology inflammation infusion injection inn interleukin interleukin17a keratinocyte lymphocytes mab monoclonal nomenclature peptide protein psoriasis secukinumab spondylitis
 
  • You are here: Home
  • Secukinumab Monoclonal Antibody Drug. Targets Interleukin-17A (IL-17A) And Is Used In Treatment Of Psoriasis. Generic Name And
x